Companies: 10,795·Total market cap: $144.5T
FSD Pharma Inc.

FSD Pharma Inc.

HUGENASDAQHealthcare
$0.09
$-0.01(-10.10%)
Market Cap$66671
P/E Ratio
52W High$109.1935
52W Low$0.087
Overview

FSD Pharma Inc.(HUGE)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HUGE · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.16huge eps ttm · huge earnings per shareEarnings history
PE Ratio (TTM)huge pe ratio ttm · huge price to earningsPE Ratio deep dive
Revenue (TTM)0.00huge revenue ttm · huge annual revenueFull revenue history
Dividend Yield不分红does huge pay dividends · huge dividend yieldDividend history
Shares Outstanding39.6Mhuge shares outstanding · huge floatShares outstanding history
Next EarningsTBAhuge earnings date · huge next earningsEarnings history

财务快照

完整财报
FY 2023Revenue$0.00
202120222023
fsd pharma inc. revenue · huge revenue 2023
FY 2023Net Income-$18.6M▲ +20.40% YoY
202120222023
fsd pharma inc. net income · huge profit 2023
FY 2023EPS$-0.47▲ +21.67% YoY
202120222023
huge eps · fsd pharma inc. earnings per share 2023
TTM:Revenue: $0.00Net Income: -$7.5MEPS: $-0.16View income statement →

股票表现

完整历史
1D+0.00%
1W-97.93%
1M-98.62%
3M-99.36%
YTD-99.85%
1Y-99.90%
5Y-99.99%

关于 FSD Pharma Inc.

CEOZeeshan Saeed
IPO DateJun 8, 2018
Employees17
CountryCA

FSD Pharma Inc. is a biopharmaceutical research and development company, operating through its various subsidiaries. The firm's leading drug candidate, FSD-201, is currently undergoing Phase II clinic…

what is fsd pharma inc. · huge stock overview · fsd pharma inc. company profile · who is fsd pharma inc. ceo · huge NASDAQ · fsd pharma inc. headquarters · fsd pharma inc. business segments

关于股票概览与关键数据

FSD Pharma Inc.(HUGE)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Jun 8, 2018 在 NASDAQ 上市。截至最近交易日,HUGE 股价为 $0.09,市值约为 $66,671。过去12个月累计回报 -99.90%,年初至今回报 -99.85%。

2023 财年 FSD Pharma Inc. 营收 —。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,FSD Pharma Inc.(HUGE)股价为 $0.09,在 NASDAQ 上市,52周区间为 $0.09 – $109.19。

HUGE 最新股价HUGE quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议